Safety assessment of gadopentetate dimeglumine in U.S. clinical trials

Radiology

Volumn 174, Issue 1, 1990, Pages 17-23

  Goldstein, H A ^a   Kashanian, F K ^a   Blumetti, R F ^a   Holyoak, W L ^a   Hugo, F P ^a   Blumenfield, D M ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

contrast media, complications; contrast media, effects; contrast media, toxicity; gadolinium

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG SAFETY; DRUG TOXICITY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; PRIORITY JOURNAL; SCHOOL CHILD; VERTIGO;

EID: 0025099367     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.174.1.2403679     Document Type: Article

References (0)